Page 1 of 63
NURS 5432 FNP I FINAL EXAM – 2026 MODULES 7–10 FNP
FOUNDATION UNIVERSITY OF TEXAS AT ARLINGTON
COMPLETE (300) CURRENT TESTING QUESTIONS AND
CORRECT ANSWERS WITH DETAILED RATIONALES.
NURS
Prepare for the NURS 5432 FNP I Final Exam with this comprehensive study resource
designed to reinforce essential family nurse practitioner concepts, comprehensive
health assessment, differential diagnosis, evidence-based treatment planning,
pharmacologic management, health promotion, disease prevention, and primary
care clinical decision-making. This document helps you review key topics, assess
your understanding, and identify areas that may require additional study before the
final exam. Use it to strengthen your advanced practice nursing knowledge and build
confidence through focused, organized preparation. An excellent companion for
successful NURS 5432 FNP I Final Exam preparation.
MULTIPLE CHOICE.
Module 7: Chronic Disease Management (Questions 1–80)
1. A 55-year-old with hypertension and DM has BP 148/90. First-line medication?
A. HCTZ
B. Lisinopril
C. Amlodipine
D. Metoprolol
Rationale: ACEi/ARB preferred in diabetes for renal protection.
2. A patient with DM and CKD (eGFR 45) has A1c 8.0%. Which medication is preferred?
A. Metformin alone
B. Empagliflozin
C. Glipizide
D. Pioglitazone
Rationale: SGLT2i reduces CKD progression and CV events.
3. LDL goal for a patient with diabetes and ASCVD?
A. <100 mg/dL
B. <70 mg/dL
C. <55 mg/dL
D. <130 mg/dL
*Rationale: Very high-risk patients (DM + ASCVD) LDL <55 mg/dL.*
, Page 2 of 63
4. A 65-year-old with HFrEF (EF 35%) on metoprolol, lisinopril, furosemide. Add for
mortality benefit?
A. Digoxin
B. Spironolactone
C. Hydralazine
, Page 3 of 63
D. Amiodarone
Rationale: MRA reduces mortality in HFrEF.
5. A patient with COPD, FEV1 50%, frequent exacerbations. GOLD group E. Initial
therapy?
A. LABA alone
B. LAMA alone
C. LAMA + LABA
D. ICS alone
*Rationale: Group E: LAMA + LABA; add ICS if eosinophils ≥300.*
6. A 70-year-old with osteoporosis, T-score -2.8 at femoral neck. First-line therapy?
A. Calcium + vitamin D
B. Alendronate
C. Raloxifene
D. Teriparatide
Rationale: Bisphosphonates first-line for osteoporosis.
7. A patient with CKD stage 4 (eGFR 25) and hyperkalemia (K 5.8). Which medication
should be held?
A. Furosemide
B. Spironolactone
C. Atorvastatin
D. Levothyroxine
Rationale: MRAs increase potassium; hold if K >5.5.
8. A 60-year-old with osteoarthritis and moderate knee pain. First-line treatment?
A. Acetaminophen
B. Topical NSAID
C. Oral NSAID
D. Tramadol
Rationale: Topical NSAID first-line; oral if inadequate.
9. A patient with gout and CKD stage 3 starts allopurinol. Starting dose?
A. 300 mg daily
B. 50–100 mg daily
C. 100 mg BID
, Page 4 of 63
D. 600 mg daily
Rationale: Start low in CKD (50–100 mg) and titrate.
10. A 65-year-old with BPH, AUA symptom score 18. First-line medical therapy?
A. Finasteride
B. Tamsulosin
C. Dutasteride
D. Surgery
Rationale: Alpha-blockers provide rapid symptom relief.
11. A patient with HFpEF and hypertension. First-line medication?
A. Beta-blocker
B. Spironolactone
C. Digoxin
D. Hydralazine
Rationale: MRAs and SGLT2i improve outcomes in HFpEF.
12. A 50-year-old with type 2 DM, A1c 7.5%, BMI 35, no ASCVD. Add to metformin?
A. Glipizide
B. Semaglutide
C. Insulin glargine
D. Pioglitazone
*Rationale: GLP-1 agonists preferred for weight loss and CV benefit.*
13. A patient with COPD on triple therapy (ICS/LABA/LAMA) has eosinophils 450. Benefit
of ICS?
A. No benefit
B. Reduces exacerbations
C. Worsens outcomes
D. Only for asthma
Rationale: Eosinophils ≥300 predict ICS response.
14. A 75-year-old with Alzheimer's disease, MMSE 18, no behavioral issues. Start?
A. Memantine
B. Donepezil
C. Vitamin E
NURS 5432 FNP I FINAL EXAM – 2026 MODULES 7–10 FNP
FOUNDATION UNIVERSITY OF TEXAS AT ARLINGTON
COMPLETE (300) CURRENT TESTING QUESTIONS AND
CORRECT ANSWERS WITH DETAILED RATIONALES.
NURS
Prepare for the NURS 5432 FNP I Final Exam with this comprehensive study resource
designed to reinforce essential family nurse practitioner concepts, comprehensive
health assessment, differential diagnosis, evidence-based treatment planning,
pharmacologic management, health promotion, disease prevention, and primary
care clinical decision-making. This document helps you review key topics, assess
your understanding, and identify areas that may require additional study before the
final exam. Use it to strengthen your advanced practice nursing knowledge and build
confidence through focused, organized preparation. An excellent companion for
successful NURS 5432 FNP I Final Exam preparation.
MULTIPLE CHOICE.
Module 7: Chronic Disease Management (Questions 1–80)
1. A 55-year-old with hypertension and DM has BP 148/90. First-line medication?
A. HCTZ
B. Lisinopril
C. Amlodipine
D. Metoprolol
Rationale: ACEi/ARB preferred in diabetes for renal protection.
2. A patient with DM and CKD (eGFR 45) has A1c 8.0%. Which medication is preferred?
A. Metformin alone
B. Empagliflozin
C. Glipizide
D. Pioglitazone
Rationale: SGLT2i reduces CKD progression and CV events.
3. LDL goal for a patient with diabetes and ASCVD?
A. <100 mg/dL
B. <70 mg/dL
C. <55 mg/dL
D. <130 mg/dL
*Rationale: Very high-risk patients (DM + ASCVD) LDL <55 mg/dL.*
, Page 2 of 63
4. A 65-year-old with HFrEF (EF 35%) on metoprolol, lisinopril, furosemide. Add for
mortality benefit?
A. Digoxin
B. Spironolactone
C. Hydralazine
, Page 3 of 63
D. Amiodarone
Rationale: MRA reduces mortality in HFrEF.
5. A patient with COPD, FEV1 50%, frequent exacerbations. GOLD group E. Initial
therapy?
A. LABA alone
B. LAMA alone
C. LAMA + LABA
D. ICS alone
*Rationale: Group E: LAMA + LABA; add ICS if eosinophils ≥300.*
6. A 70-year-old with osteoporosis, T-score -2.8 at femoral neck. First-line therapy?
A. Calcium + vitamin D
B. Alendronate
C. Raloxifene
D. Teriparatide
Rationale: Bisphosphonates first-line for osteoporosis.
7. A patient with CKD stage 4 (eGFR 25) and hyperkalemia (K 5.8). Which medication
should be held?
A. Furosemide
B. Spironolactone
C. Atorvastatin
D. Levothyroxine
Rationale: MRAs increase potassium; hold if K >5.5.
8. A 60-year-old with osteoarthritis and moderate knee pain. First-line treatment?
A. Acetaminophen
B. Topical NSAID
C. Oral NSAID
D. Tramadol
Rationale: Topical NSAID first-line; oral if inadequate.
9. A patient with gout and CKD stage 3 starts allopurinol. Starting dose?
A. 300 mg daily
B. 50–100 mg daily
C. 100 mg BID
, Page 4 of 63
D. 600 mg daily
Rationale: Start low in CKD (50–100 mg) and titrate.
10. A 65-year-old with BPH, AUA symptom score 18. First-line medical therapy?
A. Finasteride
B. Tamsulosin
C. Dutasteride
D. Surgery
Rationale: Alpha-blockers provide rapid symptom relief.
11. A patient with HFpEF and hypertension. First-line medication?
A. Beta-blocker
B. Spironolactone
C. Digoxin
D. Hydralazine
Rationale: MRAs and SGLT2i improve outcomes in HFpEF.
12. A 50-year-old with type 2 DM, A1c 7.5%, BMI 35, no ASCVD. Add to metformin?
A. Glipizide
B. Semaglutide
C. Insulin glargine
D. Pioglitazone
*Rationale: GLP-1 agonists preferred for weight loss and CV benefit.*
13. A patient with COPD on triple therapy (ICS/LABA/LAMA) has eosinophils 450. Benefit
of ICS?
A. No benefit
B. Reduces exacerbations
C. Worsens outcomes
D. Only for asthma
Rationale: Eosinophils ≥300 predict ICS response.
14. A 75-year-old with Alzheimer's disease, MMSE 18, no behavioral issues. Start?
A. Memantine
B. Donepezil
C. Vitamin E
